Mizuho Medy Co.,Ltd.
TSE:4595.T
1477 (JPY) • At close December 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) JPY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 10,989.735 | 17,581.83 | 12,886.27 | 4,203.303 | 6,426.91 | 6,425.082 | 5,623.976 | 4,962.189 | 4,083.053 | 3,997.355 | 3,248 |
| Cost of Revenue
| 2,915.687 | 3,481.757 | 3,234.206 | 1,444.516 | 2,087.6 | 2,098.575 | 1,964.856 | 1,771.634 | 1,422.431 | 1,348.183 | 1,145 |
| Gross Profit
| 8,074.048 | 14,100.073 | 9,652.064 | 2,758.787 | 4,339.31 | 4,326.507 | 3,659.12 | 3,190.555 | 2,660.622 | 2,649.172 | 2,103 |
| Gross Profit Ratio
| 0.735 | 0.802 | 0.749 | 0.656 | 0.675 | 0.673 | 0.651 | 0.643 | 0.652 | 0.663 | 0.647 |
| Reseach & Development Expenses
| 669.081 | 605.465 | 592.315 | 509.46 | 461.923 | 460.658 | 386.342 | 356.999 | 306.697 | 285.908 | 258 |
| General & Administrative Expenses
| 419.12 | 575.452 | 503.875 | 246.906 | 310.073 | 290.359 | 267.82 | 356.905 | 344.793 | 279.789 | 58 |
| Selling & Marketing Expenses
| 1,785.528 | 0 | 224.336 | 384.573 | 1,053.917 | 1,044.647 | 991.899 | 1,004.224 | 727.981 | 777.735 | 576 |
| SG&A
| 2,204.648 | 575.452 | 728.211 | 631.479 | 1,363.99 | 1,335.006 | 1,259.719 | 1,361.129 | 1,072.774 | 1,057.524 | 1,632 |
| Other Expenses
| 48.332 | 7.211 | 0.674 | 0.831 | 1.55 | -8.873 | 1.338 | -2.197 | 2.327 | 1.859 | 0 |
| Operating Expenses
| 2,922.061 | 2,995.863 | 2,953.56 | 2,342.562 | 3,228.226 | 3,105.788 | 2,808.677 | 2,335.206 | 1,973.82 | 1,908.715 | 1,891 |
| Operating Income
| 5,151.987 | 11,104.204 | 6,698.497 | 416.222 | 1,111.077 | 1,220.713 | 850.439 | 529.438 | 388.333 | 465.088 | 200 |
| Operating Income Ratio
| 0.469 | 0.632 | 0.52 | 0.099 | 0.173 | 0.19 | 0.151 | 0.107 | 0.095 | 0.116 | 0.062 |
| Total Other Income Expenses Net
| 140.485 | -33.318 | 126.018 | -1.05 | 59.707 | -8.92 | 0.686 | -4.269 | -18.585 | -5.751 | 5 |
| Income Before Tax
| 5,292.472 | 11,070.886 | 6,824.515 | 415.172 | 1,170.784 | 1,211.793 | 851.125 | 524.731 | 369.748 | 459.337 | 205 |
| Income Before Tax Ratio
| 0.482 | 0.63 | 0.53 | 0.099 | 0.182 | 0.189 | 0.151 | 0.106 | 0.091 | 0.115 | 0.063 |
| Income Tax Expense
| 1,518.232 | 3,232.791 | 2,007.742 | 108.826 | 296.439 | 292.587 | 191.076 | 129.525 | 112.147 | 142.04 | 66 |
| Net Income
| 3,774.239 | 7,838.094 | 4,816.772 | 306.346 | 874.344 | 919.205 | 660.049 | 395.205 | 257.601 | 317.297 | 139 |
| Net Income Ratio
| 0.343 | 0.446 | 0.374 | 0.073 | 0.136 | 0.143 | 0.117 | 0.08 | 0.063 | 0.079 | 0.043 |
| EPS
| 396.27 | 822.94 | 505.72 | 32.16 | 91.8 | 96.51 | 69.3 | 41.49 | 30.31 | 37.51 | 65.72 |
| EPS Diluted
| 396.27 | 822.94 | 505.72 | 32.16 | 91.8 | 96.51 | 69.3 | 41.49 | 30.31 | 37.51 | 65.72 |
| EBITDA
| 5,347.482 | 11,228.661 | 6,998.356 | 611.107 | 1,339.933 | 1,299.275 | 929.705 | 592.793 | 426.883 | 515.16 | 213 |
| EBITDA Ratio
| 0.487 | 0.64 | 0.533 | 0.145 | 0.199 | 0.204 | 0.165 | 0.185 | 0.178 | 0.198 | 0.066 |